BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19349881)

  • 1. "Hand-foot" syndrome-an unusual case of plantar pathology presenting to a burns unit.
    Goutos I; Kaniorou-Larai M; Dziewulski P
    J Burn Care Res; 2009; 30(3):529-32. PubMed ID: 19349881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is pyridoxine helpful in preventing palmar-plantar erythrodysesthesia associated with capecitabine?
    Jeung HC; Chung HC
    Asia Pac J Clin Oncol; 2010 Sep; 6(3):141-3. PubMed ID: 20887492
    [No Abstract]   [Full Text] [Related]  

  • 3. [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].
    Agharbi FZ; Meziane M; Benhemmne H; Daoudi K; Elmesbahi O; Mikou O; Mernissi FZ
    Ann Dermatol Venereol; 2012 Mar; 139(3):221-2. PubMed ID: 22401689
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of hand-foot syndrome in patient treated with capecitabine].
    Fujii C; Anami S; Fujino M; Yasui Y; Fujita M; Inoue M; Nakayama T; Kamigaki S; Tatsuta M; Furukawa H
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1357-60. PubMed ID: 18701848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Breast cancer and the hand-foot syndrome].
    Llambrich C; Falcou MC; De Rycke Y; Cottu P; Carrié S; Medjbari M
    Soins; 2012 Jun; (766):25-8. PubMed ID: 22870762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hand-foot syndrome with capecitabine therapy].
    Marini A; Hengge UR
    Hautarzt; 2007 Jun; 58(6):532-6. PubMed ID: 16897045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy traces on hands and feet in a patient with colon cancer].
    Stiefelhagen P
    MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():9. PubMed ID: 22916416
    [No Abstract]   [Full Text] [Related]  

  • 8. Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.
    Tavares-Bello R
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1434-5. PubMed ID: 17958867
    [No Abstract]   [Full Text] [Related]  

  • 9. [A woman with palmar and plantar hyperpigmentation].
    van Tienhoven G; Wilmink JW
    Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hand-foot syndrome induced by capecitabine.
    Gressett SM; Stanford BL; Hardwicke F
    J Oncol Pharm Pract; 2006 Sep; 12(3):131-41. PubMed ID: 17022868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmar-plantar erythrodysesthesia associated with scrotal and penile involvement with capecitabine.
    Sapp CM; DeSimone P
    Clin Colorectal Cancer; 2007 Jan; 6(5):382-5. PubMed ID: 17311704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance and effective management of the hand-foot syndrome in colon cancer patients receiving capecitabine as adjuvant chemotherapy.
    Son HS; Lee WY; Lee WS; Yun SH; Chun HK
    Yonsei Med J; 2009 Dec; 50(6):796-802. PubMed ID: 20046420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unilateral acral necrosis as a minor form of hand-foot syndrome. Patient with unilateral acral necrosis secondary to capecitabine therapy for metastatic breast cancer].
    Sauter C; Saborowski A; Ockenfels HM
    Hautarzt; 2007 Jul; 58(7):619-22. PubMed ID: 17066280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
    Risum S; Langer SW
    Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capecitabine and hand-foot syndrome.
    Saif MW
    Expert Opin Drug Saf; 2011 Mar; 10(2):159-69. PubMed ID: 21174613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capecitabine-induced hypertriglyceridemia and hyperglycemia: two cases.
    Duman BB; Paydas S; Tetiker T; Gunaldı M; Afsar CU; Erçolak V; Haksöyler V; Dilli MŞ
    Pharmacology; 2012; 90(3-4):212-5. PubMed ID: 23038659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hand and foot syndrome secondary to capecitabine.
    Lal HS
    Indian J Dermatol Venereol Leprol; 2014; 80(5):427-30. PubMed ID: 25201844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine.
    Disel U; Gürkut O; Abali H; Kaleağasi H; Mertsoylu H; Ozyilkan O; Saif MW
    Cutan Ocul Toxicol; 2010 Jun; 29(2):140-2. PubMed ID: 20298142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
    Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertriglyceridaemia-induced pancreatitis: a contributory role of capecitabine?
    Chan HY; Ng CM; Tiu SC; Chan AO; Shek CC
    Hong Kong Med J; 2012 Dec; 18(6):526-9. PubMed ID: 23223655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.